23 July 2024 in Biotechnology and Bioengineering
VYVenkata V. B. Yallapragada
Venkata V. B. Yallapragada
In the burgeoning field of proteins, the effective analysis of intricate protein data remains a formidable challenge, necessitating advanced computational tools for data processing, feature extraction, and interpretation. This study introduces ProteinFlow, an innovative framework designed to revolutionize feature engineering in protein data analysis. ProteinFlow stands out by offering enhanced efficiency in data collection and preprocessing, along with advanced capabilities in feature extraction, directly addressing the complexities inherent in multidimensional protein data sets. Through a comparative analysis, ProteinFlow demonstrated a significant improvement over traditional methods, notably reducing data preprocessing time and expanding the scope of biologically significant features identified. The framework's parallel data processing strategy and advanced algorithms ensure not only rapid data handling but also the extraction of comprehensive, meaningful insights from protein sequences, structures, and interactions. Furthermore, ProteinFlow exhibits remarkable scalability, adeptly managing large‐scale data sets without compromising performance, a crucial attribute in the era of big data.
7 October 2025 in PLOS Computational Biology
VYVenkata V. B. Yallapragada
Venkata V. B. Yallapragada
Deep learning for protein function prediction faces significant challenges in identifying disease-specific proteins. We present Extracellular Matrix Protein Predictor (EPOP), an advanced transfer learning framework leveraging protein language models to decode disease mechanisms. Focusing on pelvic organ prolapse (POP), which affects up to 50% of women worldwide, EPOP demonstrates AI’s power to reveal novel therapeutic targets. We developed a sophisticated fine-tuning protocol for the ESM-2 model, optimized for ECM protein prediction. Our architecture integrates specialized attention mechanisms with interpretability modules, trained on expertly curated and balanced datasets totaling 80,000 proteins (40,000 ECM and 40,000 non-ECM). The framework employs a novel validation strategy using a 16,000-sample independent test set and clinical proteomics data. EPOP achieved unprecedented performance (99.40% accuracy) in ECM protein classification, significantly surpassing traditional deep learning architectures (10.81% improvement over Transformer models, 21.71% over Long Short-Term Memory). Applied to clinical samples, our model revealed a previously unknown pattern of ECM remodeling, identifying 24 novel disease-associated proteins. Model interpretability analysis uncovered specific sequence motifs and structural features critical for ECM protein function, providing mechanistic insights into disease progression. EPOP demonstrates how advanced AI bridges molecular analysis and clinical applications, uncovering novel therapeutic targets. Its success suggests broader applications across ECM-related disorders, potentially transforming approaches to diseases affecting connective tissue architecture.
1 January 2024 in Digital Health
Background: This article presents medical software-as-a-virtual service platform, a comprehensive telemedicine solution integrating software-as-a-service principles with user-centric features to enhance healthcare service efficiency, accessibility, and patient–provider interaction. Methods: Medical software-as-a-virtual service employs a multifaceted approach, incorporating a robust questionnaire system for data collection and an empathetic virtual agent module to facilitate nuanced patient–provider interactions. The platform prioritizes privacy and data security through advanced encryption standard encryption and data anonymization, aligning with Health Insurance Portability and Accountability Act standards. Results: The initial deployment of medical software-as-a-virtual service demonstrates significant improvements in data collection efficiency, patient engagement, and healthcare service quality. The platform’s adaptability is evidenced by its successful application in specialized fields such as radiology and prolapse. User feedback underscores the system’s ease of use and potential for reducing healthcare providers’ workload. Discussion: Despite its promising outcomes, medical software-as-a-virtual service faces challenges, including the need for in-person treatment and limited virtual agent customization. Short-term improvements aim to enhance appointment scheduling, speech recognition, and agent personalization. Long-term goals include integrating artificial intelligence for diagnostic assistance, Internet of Things for comprehensive remote care, and advanced virtual agents for improved patient interaction. Conclusion: Medical software-as-a-virtual service emerges as a transformative telemedicine solution, effectively addressing contemporary healthcare challenges. Its continuous evolution, marked by the integration of advanced technologies and user-centered design, holds the potential to reshape the landscape of remote healthcare delivery. Future research will focus on refining platform features and examining the broader impact on healthcare systems and patient outcomes.